Tesarakt, founded in 2022, is positioning itself as a leading developer in the medtech space with its focus on AI For Medical Imaging. The company offers a Comprehensive and real time full body imaging AI suite, which is geared toward enhancing diagnostic accuracy and efficiency in medical facilities. By utilizing advanced AI technologies, the company aims to streamline how healthcare professionals interpret medical images, potentially reducing human error and improving patient outcomes.
Based in the United States, Tesarakt captured the interest of the venture capital community shortly after its inception. Its initial Seed investment round on 01 April 2022 was backed by reputable investors including SOSV and indiebio. This early support underscores the market's trust in Tesarakt's innovative approach and its potential to disrupt the conventional medical imaging paradigm.